Previous Karolinska Immunology Seminar Series (KiSS) 2020-2021

Karolinska Immunology Seminar Series (KiSS)


Spring 2020:

Thursday, 27.02.2020, 15:00-16:00

 Marc Jenkins (University of Minnesota, USA)    

Title: Differentiation of antigen-specific CD4+ T cells during infection


Thursday, 19.03.2020, 15:00-16:00    

Joseph Sun (Memorial Sloan Kettering Cancer Center, USA)  

Title: Epigenetic control of innate and adaptive lymphocytes


Thursday, 02.04.2020, 15:00-16:00    

Bruno Silva-Santos (University of Lisbon, Portugal)

Title: Differentiation of gamma-delta T cell subsets: implications for Neuro- and Onco-Immunology


Thursday, 23.04.2020, 15:00-16:00     

Ziv Shulman (Weizmann Institute of Science, Israel)    

Title: Germinal centers: a game of clones in immunological niches


Thursday, 28.05.2020, 15:00-16:00     

Sten Eirik Jacobsen (KI, Sweden and University of Oxford, UK) 

Title: Lineage-Restricted Fates of Multipotent Hematopoietic Stem Cells

Autumn 2020:


Thursday, 24.09.2020, 9:00-10:00

Robert Brink (Garvan Institute of Medical Research, Sydney, Australia)

Title: Class, position and the germinal centre B cell


Thursday, 01.10.2020, 15:00-16:00

John Wherry (University of Pennsylvania, Philadelphia, USA)

Title: T cell exhaustion and immune profiling in disease


Thursday, 15.10.2020, 15:00-16:00

Judith Allen (University of Manchester, UK)

Title: Learning from helminths: macrophages, type 2 immunity & Tissue repair


Thursday, 12.11.2020, 15:00-16:00

Erika Pearce (Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany)

Title: Polyamine metabolism regulates the T cell epigenome through hypusination


Thursday, 19.11.2020, 15:00-16:00

Jun Huh (Harvard University, Boston, USA)

Title: Immune modulatory roles of the microbial metabolites of bile acids


Spring 2021:

Thursday, 21.01.2021, 15:00-16:00

Gabriel Victora (Rockefeller University, New York, USA)

Title: Clonal dynamics of the antibody response


Thursday, 11.02.2021, 15:00-16:00

Adrian Liston (Babraham Institute, Cambridge, UK)

Title: Using brain regulatory T cells to fight neuroinflammation


Thursday, 11.03.2021, 15:00-16:00

Michel Sadelain (Memorial Sloan Kettering Cancer Center, New York, USA)

Title: CD19 CARs–paving the road to synthetic immunity


Thursday, 25.03.2021, 15:00-16:00

Soumya Raychaudhuri (Harvard University, Boston, USA)

Title: The genetics and genomics of rheumatoid arthritis


Thursday, 29.04.2021, 15:00-16:00

Ton Schumacher (The Netherlands Cancer Institute, Amsterdam)

Title: T cell activity in human cancer


Thursday, 27.05.2021, 15:00-16:00

Gillian Griffiths (University of Cambridge, UK) 

Title: Identifying single genes that impact T cell effector function 


Autumn 2021:

Thursday, 2021-10-14, 15:00-16:00 

Gunilla Karlsson Hedestam (Karolinska Institutet, Sweden) 

Title: Characterization of human TCR and BCR VDJ genes reveals a high degree of diversity between individuals and multiple population-enriched alleles


Thursday, 2021-10-21, 15:00-16:00 

Hans-Reimer Rodewald (DKFZ, Germany) 

Title: PolyloxExpress resolves fates and transcriptomes of hematopoietic stem cells 


Thursday, 2021-10-28, 15:00-16:00 

Meinrad Busslinger (IMP, Austria) 

Title: Role of Pax5 in B cell immunity and disease


Thursday, 2021-11-11, 15:00-16:00 

Adrian Hayday (King's College London and the Francis Crick Institute, UK) 

Title: Gamma-Delta T cells: an unique, conserved adaptive response distinguishing cell pathology from normality


Thursday, 2021-11-18, 15:00-16:00 

Mihai Netea (Radboud University, Netherlands)

Title: Trained immunity: a memory for innate host defense


Thursday, 2021-12-02, 15:00-16:00 

Olivier Lantz (Institut Curie, France) 

Title: MAIT cells: development and functions

Thursday, 2021-12-09, 15:00-16:00

Thursday, 2021-12-16, 15:00-16:00

Ana Carrizosa Anderson (Harvard Medical School, USA) 

Title: Analyses of temporal and inter-cancer heterogeneity provide new insights into T cell dysfunction


Thursday, 2021-12-16, 15:00-16:00 

Akiko Iwasaki (Yale University, USA)
Title: Immune responses to SARS-CoV-2